BIRC5 and pulmonary arterial hypertension: Given that we previously demonstrated that Survivin is overexpressed in PAH-PASMCs contributing to the development of PAH7, 51, HDAC6 inhibition may also contribute to improve PAH by reducing the cytoplasmic pool of Survivin leading to increased sensitivity to apoptosis.